Dicloxacillin Sodium is an isoxazolyl penicillin resistant to staphylococcal beta-lactamase, used orally for penicillinase-producing Staphylococcus aureus infections of skin, soft tissue and bone. Simson Pharma's Dicloxacillin Sodium reference standard and impurities support compendial testing for this beta-lactamase-stable penicillin.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Dicloxacillin Sodium Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.